Re:In China, Desperate Patients Smuggle Drugs or Make Their Own
by refurb on Monday November 12, 2018 @09:35PM
(#18437971)
No offense but the article you referenced is misleading.
Sure, just the trial might cost that little if it’s an orphan disease, but it’s also ignoring all the other stuff that goes along with running a trial. Things like manufacturing, compliance, data analysis, etc.
When you look at the total cost of R&D for a drug, it’s typically 1/3 for discovery and 2/3 for development (clinical trials).
If your drug is used in any reasonable sized population, development is easily in the hundreds of millions of dollars.
You are correct about the failure rates though.
The long line of failed drugs are the real issue.